Ireland
--:--IST
Active, not recruiting Not applicable

The Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and Vomiting

NCT07456982 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-01-30
Last updated
2026-03-09

Condition(s) studied

Nausea and Vomiting Chemotherapy-InducedHematological Malignancies

Investigational drug(s) / intervention(s)

Relaxation breathing exerciseControl group

Relaxation breathing exercise: Relaxation breathing exercise: 1. Preliminary exercise: Participants lie comfortably on their backs in the bed and focus on the lower abdomen. They place their left ankles over their right knees and then place their right ankles over their left knees. They draw both knees toward their abdomens. 2. Relaxation breathing: Participants relax while breathing deeply through their noses and letting them out through their mouths slowly. They count to four and breathe in deeply, they hold their breathe while counting to four, and breathe out while counting to eight. 3. Ending exercise: Participants stretch their arms and legs and then loosen them. They relax the muscles concerned with their faces, shoulders and eyebrows by keeping their mind clear.

Control group: Control group does not perform relaxation breathing exercise. They only receive standard treatment.

Study summary

The Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and Vomiting in Patients With Hematological Malignancies ABSTRACT

Background:

Chemotherapy is widely used in the treatment of hematological malignancies despite it has important and difficult side effects in patients. Chemotherapy induced nausea and vomiting are among the most common side effects in patients and antiemetic drugs may not be always curative.

Purpose:

This research aimed to determine the effectiveness of relaxation breathing exercise on managing chemotherapy induced nausea and vomiting in patients with hematological malignancies undergoing chemotherapy.

Method:

A randomized controlled trial design was conducted with a total of selected sixty eight patients with hematological malignancies (34 intervention and 34 control participants) undergoing chemotherapy hospitalized in the hematology clinic of a Training and Research Hospital. The intervention group implemented relaxation breathing exercise three times a day with a standard treatment protocol and the control group only received routine drug treatment for chemotherapy induced nausea and vomiting. Nausea and vomiting were assessed by filling Rhodes Index of Nausea Vomiting and Retching (RINVR) for the first six days after the start of the chemotherapy.

Results:

Data collection process ended. Data analysis process is in progress.

Conclusion:

In this study the effectiveness of relaxation breathing exercise on chemotherapy related nausea and vomiting will be examined in patients with hematological malignancies.

Keywords: Relaxation breathing exercise; Hematological malignancies; Chemotherapy; Nausea and vomiting

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 18 years or over with hematological malignancies * Undergoing chemotherapy * Not having any communication problems (able to read, write and speak Turkish. Exclusion Criteria: * Having psychiatric and mental problems * Receiving radiotherapy concurrent with chemotherapy, 3) Having respiratory distress * Having central nervous system involvement * Having Grade 3 or Grade 4 nausea and vomiting.

Primary outcome measure(s)

  • Change from the start of the chemotherapy in the frequency and severity of nasea, vomiting and retching at 6 days. — From enrollment to the end of intervention at 6 days
    Zero is equivalent to no nausea, no vomiting and no retching and 4 indicates the worst and unbearable nausea, vomiting and retching

Trial sites (1)

FacilityCityRegionStatus
Marmara University, Mehmet Genç Complex Istanbul Kartal
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07456982 on ClinicalTrials.gov ↗ ← All trials in Turkey